The microsurgical treatment for primary hypertensive brainstem hemorrhage: Experience with 52 patients

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Primary bone lymphoma: experience with 52 patients.

BACKGROUND AND OBJECTIVES A retrospective analysis was performed to assess the efficacy of various treatments of non-Hodgkin's primary bone lymphomas (PBL). DESIGN AND METHODS Fifty-two consecutive, previously untreated PBL patients were seen between the years 1982 and 1998. Information was obtained regarding each patient's presentation and clinical course. Histology was reviewed in all cases...

متن کامل

Ultra Early Microsurgical Treatment of Hypertensive Putaminal Hemorrhage

Hypertensive putaminal bleed is the result of longstanding hypertension and atherosclerosis in the intracranial vessels.15 It is one of the most dangerous complications of hypertension. It stands about 60% of stroke that present in emergency. Hypertensive putaminal bleed is most commonly seen in age 50-60 years and there is slight male predominance.16,18 Bivek Vaidya, MS Bir Hospital National N...

متن کامل

Experience of microsurgical treatment of brainstem cavernomas: report of 37 cases.

BACKGROUND Cavernomas are rare in the brainstem and account for 18-35% of central nervous cavernomas and can cause recurrent hemorrhages, devastating neurological deficits and mortality. OBJECTIVES To summarize the experience of microsurgical treatment of brainstem cavernomas and to investigate curative effect of microsurgical treatment of brainstem cavernomas. MATERIALS AND METHODS A retro...

متن کامل

OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm

OnabotulinumtoxinA (OnabotA) was approved for treatment of chronic migraine (CM) after publication of PREEMPT trials. Thus, we set out to evaluate the efficacy of OnabotA in a series of patients with CM treated according to the PREEMPT protocol. In May 2012 we began to offer OnabotA to patients with CM who did not respond to topiramate and at least one other preventive therapy (beta blocker and...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Asian Journal of Surgery

سال: 2021

ISSN: 1015-9584

DOI: 10.1016/j.asjsur.2020.04.016